These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 32983230)
1. Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer. Wu Y; Liu Y; He A; Guan B; He S; Zhang C; Kang Z; Gong Y; Li X; Zhou L Front Genet; 2020; 11():992. PubMed ID: 32983230 [TBL] [Abstract][Full Text] [Related]
2. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. Chen F; Wang Q; Zhou Y BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397 [TBL] [Abstract][Full Text] [Related]
3. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer. Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T Front Genet; 2021; 12():696912. PubMed ID: 34512722 [No Abstract] [Full Text] [Related]
4. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer. Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989 [TBL] [Abstract][Full Text] [Related]
5. An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma. Liu D; Zhou B; Liu R PeerJ; 2020; 8():e9422. PubMed ID: 32742772 [TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes. Qiu H; Hu X; He C; Yu B; Li Y; Li J Front Genet; 2020; 11():12. PubMed ID: 32117435 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer. Du H; Li Y; Pang S; Enofe I; Pallante P; Zhu L; Hang J; Chen L J Thorac Dis; 2023 Nov; 15(11):6178-6191. PubMed ID: 38090289 [TBL] [Abstract][Full Text] [Related]
8. Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer. Dong B; Liang J; Li D; Song W; Song J; Zhu M; Zhao S; Ma Y; Yang T Front Mol Biosci; 2021; 8():688298. PubMed ID: 34368227 [No Abstract] [Full Text] [Related]
9. Identification of a Novel Ferroptosis-Related Gene Prognostic Signature in Bladder Cancer. Sun J; Yue W; You J; Wei X; Huang Y; Ling Z; Hou J Front Oncol; 2021; 11():730716. PubMed ID: 34557413 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the functions and prognostic significance of RNA-binding proteins in bladder urothelial carcinoma. Guo C; Shao T; Jiang X; Wei D; Wang Z; Li M; Bao G Am J Transl Res; 2020; 12(11):7160-7173. PubMed ID: 33312357 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases. He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970 [TBL] [Abstract][Full Text] [Related]
12. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma. Zhang C; Li Z; Hu J; Qi F; Li X; Luo J J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406 [TBL] [Abstract][Full Text] [Related]
13. Construction of cancer- associated fibroblasts related risk signature based on single-cell RNA-seq and bulk RNA-seq data in bladder urothelial carcinoma. Liu Y; Jian J; Zhang Y; Wang L; Liu X; Chen Z Front Oncol; 2023; 13():1170893. PubMed ID: 37124542 [TBL] [Abstract][Full Text] [Related]
14. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer. Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763 [TBL] [Abstract][Full Text] [Related]
15. An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer. Lian P; Wang Q; Zhao Y; Chen C; Sun X; Li H; Deng J; Zhang H; Ji Z; Zhang X; Huang Q Aging (Albany NY); 2019 Sep; 11(17):6930-6940. PubMed ID: 31479417 [TBL] [Abstract][Full Text] [Related]
16. Analysis and application of RNA binding protein gene pairs to predict the prognosis of gastric cancer. Ning ZK; Tian HK; Liu J; Hu CG; Liu ZT; Li H; Zong Z Heliyon; 2023 Jul; 9(7):e18242. PubMed ID: 37539127 [TBL] [Abstract][Full Text] [Related]
17. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma. Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J Front Genet; 2020; 11():568192. PubMed ID: 33133154 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Novel RNA-Binding Protein-Related Gene-Based Prognostic Model for Multiple Myeloma. Wang W; Xu SW; Zhu XY; Guo QY; Zhu M; Mao XL; Chen YH; Li SW; Luo WD Front Genet; 2021; 12():665173. PubMed ID: 33981333 [TBL] [Abstract][Full Text] [Related]
19. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma. Bao Z; Zhang W; Dong D Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759 [TBL] [Abstract][Full Text] [Related]
20. Construction and verification of a novel hypoxia-related lncRNA signature related with survival outcomes and immune microenvironment of bladder urothelial carcinoma by weighted gene co-expression network analysis. Cai D; Zhou Z; Wei G; Wu P; Kong G Front Genet; 2022; 13():952369. PubMed ID: 36118856 [No Abstract] [Full Text] [Related] [Next] [New Search]